We report first-time definitive evidence of human cutaneous leishmaniasis (CL) resulting from L. major infections in Ghana. The evidence is in the form of PCR testing and DNA sequence analysis of skin sample biopsies from residents of the Ho District in the forested Volta Region of southeastern Ghana ( Figure 1 ). The moist semi-deciduous forest of this region of Ghana is atypical for CL. Although two sand fly species with known or suspected potential to transmit L. major were present in communities where human cases of CL originated, they were found in such small numbers that their role in the transmission of CL is uncertain.
Twelve million people worldwide are believed to be infected with the parasites that cause leishmaniasis, and 88 different nations report this disease. 1 It is estimated that up to 75% of the 1.5 million new cases of leishmaniasis that occur each year are CL with L. major the responsible etiologic agent of this cutaneous disease in Africa and throughout Eurasia. Over this vast range, CL transmission is typically associated with arid desert and savannah conditions where the parasites are harbored in rodents and vectored by night-biting sand flies of the genus Phlebotomus.
For many years, leishmaniasis in Africa and Western Asia has been grossly underestimated; it now appears that the disease is much more prevalent than previously suspected. 1 In Ghana, CL was considered a parasitic disease risk that was limited to the arid sahel-savannah region in the north, but no infections or evidence of transmission had been actually described. Thousands of man-hours of mosquito surveillance have been conducted in northern Ghana 2 for the purpose of quantifying man-biting malaria vectors, but there is no record or report of sand flies in these collections. However, since 1999, an increasing number of suspected CL cases have been reported from the southern Volta Region of Ghana in a moist forest ecosystem where such skin lesions had not been previously reported. The assumption of CL was based subjectively on local microscopy, which identified Leishmania amastigotes in skin lesion biopsies taken from a cluster of local patients. Initial efforts of our study intended to verify the presence of Leishmania parasites by applying newly developed PCR methods to 5 previously collected, archived biopsy samples embedded in paraffin and if possible, to identify the species of parasite and its genetic relatedness to a variety of reference strains of Leishmania. Entomological surveillance based on sand flies collected from oiled paper trapping and CO 2 -baited miniature CDC light traps conducted from May 2004-February 2005 sought to identify candidate vectors and their population trends in the affected region. Subsequently, the Ghana Health Service requested PCR-based diagnoses on newly collected needle biopsies from patients seeking diagnosis and treatment of skin lesions at local health clinics and the district hospital in Ho. Diagnostic reagents were provided and technology was transferred from NAMRU-3 to the Noguchi Memorial Institute for Biomedical Research to establish methods for PCR diagnosis of Leishmaniasis in Ghana by Ghanaian investigators and healthcare workers.
Verbal informed consent was obtained from villagers with suspected leishmaniasis. The lesion site was cleaned with Betadine solution. Using a 3-cc syringe, the biopsy area was anesthetized with 1% lidocaine and draped in a sterile fashion. A ∼0.5 × 0.25 cm section of the lesion was excised with a #15 scalpel from subcutaneous fat. The elliptical section was removed and fixed in 100% ethanol for storage and transport. Adequate homeostasis was observed and a sterile dressing was applied. DNA was later extracted from paraffinembedded tissue by first making thin slices of the paraffin and subsequently removing as much of the paraffin with a scalpel as possible. Remaining sample was sliced into small pieces and no more than 25 mg of tissue was mixed with 1 mL of xylene and extracted by a standard method. 3 After paraffinremoval, DNA was extracted from the tissue using the Qiagen DNA mini kit (Qiagen, Valencia, CA) as per the manufacturer's recommendations. DNA was resuspended in 100 L of AE buffer and stored at 4°C until use.
A foot lesion from a BALB/c mouse experimentally infected with Leishmania major IPAP/EG/89/SI-177 4 was used as a positive control for genetic manipulations. The DNA was extracted from 25 mg of the mouse tissue using the Qiagen DNA mini kit. To avoid cross-contamination, the BALB/c mouse tissue was extracted in a separate room from the paraffin slices, on separate occasions, and a clean (non-infected) control was simultaneously prepared.
Target DNA was amplified from extracted DNA using previously described primers and conditions. [5] [6] [7] Primers R174 (5Ј-ggt tcc ttt cct gat tta cg) and R798 (5Ј-ggc cgg taa agg ccg aat ag) 6 were used to amplify a 603-bp product and primers LITSR (5Ј ctg gat cat ttt ccg atg) and L5.8S (5Ј tga tac cac tta tcg cac tt) 5 were used to amplify a 336-bp fragment from the DNA extracted from paraffin-embedded tissue and control DNA. Six l of paraffin-extracted and 2 L of control BALB/c DNA, respectively, were used as a template for each PCR reaction. A reaction containing no DNA was used as a negative control for each assay. Amplicons were visualized after electrophoresis through 1% agarose containing a final concentration of 10 g ml −1 ethidium bromide. Images were captured using a Kodak EDAS 290 image capture system. PCR products were processed using the Qiagen PCR cleanup kit (Qiagen, Valencia, CA) to remove excess oligonucleotide primer and to concentrate the product. PCR products were subsequently directly sequenced using Big Dye Terminator Technology (ABI Biosystems, Foster City, CA) and primers R174, R798, LITSR, and L5.8S at 3.2 pmol per reaction, using a 3100 Avant Genetic Analyzer (ABI Biosystems, Foster City, CA). DNA sequences were manipulated and analyzed using the software program pDRAW32 1.1.87 (http://www.acaclone.com) and aligned using the program Clustal X. 8 Phylogenetic and molecular evolutionary analyses were conducted using MEGA version 3.1. 9 A phylogenetic tree (Figure 2) was constructed with the unweighted pair group method with arithmetic mean analysis. 10 Evolutionary distances were calculated with the method of Jukes and Cantor. 11 Bootstrap analysis 12 was performed with 100 replicates. DNA extraction and PCR demonstrated that the paraffinembedded tissue samples from Ghanaian patients with skin lesions were positive for Leishmania species using both conventional primer sets ssu-rDNA and ITS1. The ITS1 PCR product from MHOM/GH/04/HO-004 was direct sequenced and shown to contain a HaeIII restriction site at position 132 bp. The ITS1 product would subsequently resolve into two fragments of 132 and 204 bp, consistent with the sizes shown for the ITS1 product of L. major. Interrogation of the BLAST nucleotide database revealed that the Leishmania species DNA from the Ghana paraffin-embedded tissues shared almost complete identity with the ITS1 sequences of L. major, specifically with an African isolate of L. major from Kenya.
Over 2,200 sand flies were collected during 10 consecutive . Sand fly identifications were made using the taxonomic keys of Abonnenc 13 and Niang et al. 14 Microscopic dissection and examination of 722 individual female sand flies captured in light traps revealed no Leishmania infections. Phlebotomus duboscqi, a proven vector of L. major in Senegal, Burkina Faso, Nigeria, and Kenya had been previously reported from Ghana 15 and was considered our primary suspected vector of CL in the Ho District. Surprisingly, however, P. duboscqi was near least abundant of 17 different sand fly species (including 6 new geographic records for sand flies in Ghana) that we collected and comprised only 0.1% of the total catch (Table 1) . One other suspect sand fly species, P. rodhaini, was captured for the first time in Ghana, but at similarly low numbers (0.3%), insufficient to yield a profile of seasonal abundance. In Sudan, P. rodhaini was found to harbor an unknown Leishmania species and demonstrated a clear predilection for blood feeding on rodents. 16 This is the first confirmation of L. major in Ghana. Our finding might have been expected in the arid sahel-savannah regions of northern Ghana bordering the West African L. major belt; however, the current outbreak was unexpected in its intensity and occurrence in a moist semi-deciduous forest ecosystem. This finding was especially surprising in view of the intensive entomological sampling that was conducted and results that give rise only to more questions. Significantly, we established a proven PCR-based methodology for detection and identification of Leishmania in Ghana for use by Ghanaian scientists and healthcare professionals. Ongoing epidemiologic surveillance efforts will hopefully elucidate vectors, reservoirs, and contributing factors responsible for the large occurrence and seemingly progressive spread of L. major in an area of Ghana where it was not known previously to have occurred. 
